This protocol applies to tuberculous lymphadenitis in cases without drug resistance, where a structured first-line anti-tuberculosis regimen is indicated.
Management follows a two-phase anti-tuberculosis drug regimen — an initial intensive phase combining multiple agents, followed by a continuation phase — with the full sequence and drug selection defined within the complete protocol.